Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-25 @ 2:17 AM
NCT ID:
NCT04190160
Eligibility Criteria:
Inclusion Criteria:
* frail very old type 2 diabetes patients without severe cognitive impairment and/or grave depression with 3 or more daily hypoglycaemic drug administrations
Exclusion Criteria:
* e-GFR \< 15 ml/min
* any experimental clinical trial participation or every experimental drug use in the previous 6 months before commencing this study
* every know or suspected allergic reaction to deglutec or any other GLP-1 agonist
* any known contraindication to IDegLira use (as described in product characteristics)
* Recent cancer diagnosis (\<3 y) or active radio- or chemo-therapy. Cancer diagnosis older than 3 years before commencing the study is allowed
* Mini mental state examination score lower than 14/30 and/or Activity Daily Living score lower than 1/6 and/or Instrumenctal Activity Daily Living lower than 1/8
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
75 Years
Maximum Age:
99 Years
Study:
NCT04190160
Study Brief:
Protocol Section:
NCT04190160